American drug delivery system developer Lyndra Therapeutics has raised US$55 million in a series B round of financing from Chinese private equity firm HOPU Investments and the Bill & Melinda Gates Foundation, according to an announcement yesterday. Other new investors, including Gilead Sciences, Invus and Orient Life, and existing investor Polaris Partners, also joined in the […]

Chinese PE Firm HOPU, Bill Gates Invests In Long-Acting Drug Designer Lyndra appeared first on China Money Network.